Claremont BioSolutions is Laboratory Services (Healthcare) in United States that focus on time detection business. Founded in 2006. They cover business area such as developer, manufacturer, novel instrumentation, consumable, dna, RNA, application, long-read sequence method, molecular diagnostic, science, research lysis, cell, purification, real-time detection, amplify DNA sequence, client, their work.
Laboratory Services (Healthcare)
2006
( 18 years old in 2024 )
Time Detection
-
1182 Monte Vista Avenue
Suite 11
Upland, CA 91786
United States
Private
developermanufacturernovel instrumentationconsumablednaRNAapplicationlong-read sequence methodmolecular diagnosticscienceresearch lysiscellpurificationreal-time detectionamplify DNA sequenceclienttheir work
* We use standard office opening hours in near Claremont BioSolutions's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Claremont BioSolutions is Laboratory Services (Healthcare) business from United States that founded in 2006 (18 years old in 2024), Claremont BioSolutions business is focusing on Time Detection.
Claremont BioSolutions headquarter office and corporate office address is located in 1182 Monte Vista Avenue Suite 11 Upland, CA 91786 United States.
Claremont BioSolutions was founded in United States.
In 2024, Claremont BioSolutions is currently focus on time detection sector.
Above is snippet of Google Trends for "time detection" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Claremont BioSolutions, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
